Intrinsiqs

Is EyePoint Pharmaceuticals, Inc. overvalued?

EyePoint Pharmaceuticals, Inc. (EYPT) — key valuation metrics and fundamentals.

No verdict
Price
$14.55
Fair value
Current P/E
Normal P/E
Market cap
$1.23B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares EYPT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.